메뉴 건너뛰기




Volumn , Issue , 2007, Pages 23-32

The strengths and weaknesses of VEGF adenovirus-driven angiogenesis

Author keywords

Adenoviruses; Gene expression; Gene Therapy; Gene Transfer; VEGF

Indexed keywords


EID: 84920085664     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/1-4020-5955-8_2     Document Type: Chapter
Times cited : (1)

References (37)
  • 2
    • 0037968240 scopus 로고    scopus 로고
    • Gene transfer as a tool to induce therapeutic vascular growth
    • Yla-Herttuala S, Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth. Nat Med. 2003;9:694-701.
    • (2003) Nat Med. , vol.9 , pp. 694-701
    • Yla-Herttuala, S.1    Alitalo, K.2
  • 3
    • 0037714018 scopus 로고    scopus 로고
    • Vegf-d is the strongest angiogenic and lymphangiogenic effector among vegfs delivered into skeletal muscle via adenoviruses
    • Rissanen TT, Markkanen JE, Gruchala M, Heikura T, Puranen A, Kettunen MI et al. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ Res. 2003;92:1098-1106.
    • (2003) Circ Res. , vol.92 , pp. 1098-1106
    • Rissanen, T.T.1    Markkanen, J.E.2    Gruchala, M.3    Heikura, T.4    Puranen, A.5    Kettunen, M.I.6
  • 4
    • 33644877314 scopus 로고    scopus 로고
    • Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis
    • Rissanen TT, Korpisalo P, Markkanen JE, Liimatainen T, Orden MR, Kholova I et al. Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis. Circulation. 2005;20;112: 3937-3946.
    • (2005) Circulation , vol.20 , Issue.112 , pp. 3937-3946
    • Rissanen, T.T.1    Korpisalo, P.2    Markkanen, J.E.3    Liimatainen, T.4    Orden, M.R.5    Kholova, I.6
  • 5
    • 17344371681 scopus 로고    scopus 로고
    • Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses
    • Puumalainen AM, Vapalahti M, Agrawal RS, Kossila M, Laukkanen J, Lehtolainen P et al. beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses. Hum Gene Ther. 1998;9:1769-1774.
    • (1998) Hum Gene Ther. , vol.9 , pp. 1769-1774
    • Puumalainen, A.M.1    Vapalahti, M.2    Agrawal, R.S.3    Kossila, M.4    Laukkanen, J.5    Lehtolainen, P.6
  • 6
    • 0030915715 scopus 로고    scopus 로고
    • Hcar and MCAR: The human and mouse cellular receptors for subgroup c adenoviruses and group b coxsackieviruses
    • Tomko RP, Xu R, Philipson L. HCAR and MCAR : The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A. 1997;94: 3352-3356.
    • (1997) Proc Natl Acad Sci U S A , vol.94 , pp. 3352-3356
    • Tomko, R.P.1    Xu, R.2    Philipson, L.3
  • 7
    • 0027166647 scopus 로고
    • Integrins alpha V beta 3 and alpha V beta 5 promote adenovirus internalization but not virus attachment
    • Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell. 1993;73:309-319.
    • (1993) Cell , vol.73 , pp. 309-319
    • Wickham, T.J.1    Mathias, P.2    Cheresh, D.A.3    Nemerow, G.R.4
  • 8
    • 0034654569 scopus 로고    scopus 로고
    • Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions
    • Dechecchi MC, Tamanini A, Bonizzato A, Cabrini G. Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. Virology. 2000;268:382-390.
    • (2000) Virology , vol.268 , pp. 382-390
    • Dechecchi, M.C.1    Tamanini, A.2    Bonizzato, A.3    Cabrini, G.4
  • 9
    • 0030994260 scopus 로고    scopus 로고
    • Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and b lymphoblastoid cells
    • Hong SS, Karayan L, Tournier J, Curiel DT, Boulanger PA. Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO J. 1997;16:2294-2306.
    • (1997) EMBO J. , vol.16 , pp. 2294-2306
    • Hong, S.S.1    Karayan, L.2    Tournier, J.3    Curiel, D.T.4    Boulanger, P.A.5
  • 10
    • 0034739554 scopus 로고    scopus 로고
    • Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta
    • Hiltunen MO, Laitinen M, Turunen MP, Jeltsch M, Hartikainen J, Rissanen TT et al. Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation. 2000;102:2262-2268.
    • (2000) Circulation , vol.102 , pp. 2262-2268
    • Hiltunen, M.O.1    Laitinen, M.2    Turunen, M.P.3    Jeltsch, M.4    Hartikainen, J.5    Rissanen, T.T.6
  • 11
    • 21344445050 scopus 로고    scopus 로고
    • Gene transfer using the mature form of VEGF-D reduces neointimal thickening through nitric oxide-dependent mechanism
    • Rutanen J, Turunen AM, Teittinen M, Rissanen TT, Heikura T, Koponen JK et al. Gene transfer using the mature form of VEGF-D reduces neointimal thickening through nitric oxide-dependent mechanism. Gene Ther. 2005;12:980-987.
    • (2005) Gene Ther. , vol.12 , pp. 980-987
    • Rutanen, J.1    Turunen, A.M.2    Teittinen, M.3    Rissanen, T.T.4    Heikura, T.5    Koponen, J.K.6
  • 12
    • 12144291703 scopus 로고    scopus 로고
    • Oral imatinib mesylate (STI571/GLEEVEC) improves the efficacy of local intravascular vascular endothelial growth factor-c gene transfer in reducing neointimal growth in hypercholesterolemic rabbits
    • Leppanen O, Rutanen J, Hiltunen MO, Rissanen TT, Turunen MP, Sjoblom T et al. Oral imatinib mesylate (STI571/gleevec) improves the efficacy of local intravascular vascular endothelial growth factor-C gene transfer in reducing neointimal growth in hypercholesterolemic rabbits. Circulation. 2004;109:1140-1146.
    • (2004) Circulation , vol.109 , pp. 1140-1146
    • Leppanen, O.1    Rutanen, J.2    Hiltunen, M.O.3    Rissanen, T.T.4    Turunen, M.P.5    Sjoblom, T.6
  • 13
    • 17344371184 scopus 로고    scopus 로고
    • Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia
    • Laitinen M, Mäkinen K, Manninen H, Matsi P, Kossila M, Agrawal RS et al. Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. Hum Gene Ther. 1998;9:1481-1486.
    • (1998) Hum Gene Ther , vol.9 , pp. 1481-1486
    • Laitinen, M.1    Mäkinen, K.2    Manninen, H.3    Matsi, P.4    Kossila, M.5    Agrawal, R.S.6
  • 14
    • 4644258829 scopus 로고    scopus 로고
    • Adenoviral vectors for gene transfer and therapy
    • Volpers C, Kochanek S. Adenoviral vectors for gene transfer and therapy. J Gene Med. 2004;6 Suppl 1:S164-S171.
    • (2004) J Gene Med. , vol.6 , pp. S164-S171
    • Volpers, C.1    Kochanek, S.2
  • 15
    • 0033541587 scopus 로고    scopus 로고
    • Expression of the primary coxsackie and adenovirus receptor is down regulated during skeletal muscle maturation and limits the efficacy of adenovirusmediated gene delivery to muscle cells
    • Nalbantoglu J, Pari G, Karpati G, Holland PC. Expression of the primary coxsackie and adenovirus receptor is down regulated during skeletal muscle maturation and limits the efficacy of adenovirusmediated gene delivery to muscle cells. Hum Gene Ther. 1999;10:1009-1019.
    • (1999) Hum Gene Ther , vol.10 , pp. 1009-1019
    • Nalbantoglu, J.1    Pari, G.2    Karpati, G.3    Holland, P.C.4
  • 16
    • 14044267666 scopus 로고    scopus 로고
    • Evaluation of angiogenesis and side effects in ischemic rabbit hindl imbs after intramuscular injection of adenoviral vectors encoding VEGF and Lacz
    • Vajanto I, Rissanen TT, Rutanen J, Hiltunen MO, Tuomisto TT, Arve K et al. Evaluation of angiogenesis and side effects in ischemic rabbit hindl imbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ. J Gene Med. 2002;4:371-380.
    • (2002) J Gene Med. , vol.4 , pp. 371-380
    • Vajanto, I.1    Rissanen, T.T.2    Rutanen, J.3    Hiltunen, M.O.4    Tuomisto, T.T.5    Arve, K.6
  • 17
    • 10744232374 scopus 로고    scopus 로고
    • Adenoviral catheter-mediated intra myocardial gene transfer using the mature form of vascular endothelial growth factor -d induces trans mural angiogenesis in porcine heart
    • Rutanen J, Rissanen TT, Markkanen JE, Gruchala M, Silvennoinen P, Kivela A et al. Adenoviral Catheter-Mediated Intramyocardial Gene Transfer Using the Mature Form of Vascular Endothelial Growth Factor -D Induces Trans mural Angiogenesis in Porcine Heart. Circulation. 2004;109: 1029-1035.
    • (2004) Circulation , vol.109 , pp. 1029-1035
    • Rutanen, J.1    Rissanen, T.T.2    Markkanen, J.E.3    Gruchala, M.4    Silvennoinen, P.5    Kivela, A.6
  • 18
    • 0032813580 scopus 로고    scopus 로고
    • Vascular permeability effect of adenovirus-mediated vascular endothelial growth factor gene transfer to the rabbit and rat skeletal muscle
    • Poliakova L, Kovesdi I, Wang X, Capogrossi MC, Talan M. Vascular permeability effect of adenovirus-mediated vascular endothelial growth factor gene transfer to the rabbit and rat skeletal muscle. J Thorac Cardiovasc Surg. 1999;118:339-347.
    • (1999) J Thorac Cardiovasc Surg. , vol.118 , pp. 339-347
    • Poliakova, L.1    Kovesdi, I.2    Wang, X.3    Capogrossi, M.C.4    Talan, M.5
  • 19
    • 32944459691 scopus 로고    scopus 로고
    • Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy
    • Thirion C, Lochmuller H, Ruzsics Z, Boelhauve M, Konig C, Thedieck C et al. Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy. Hum Gene Ther. 2006;17:193-205.
    • (2006) Hum Gene Ther , vol.17 , pp. 193-205
    • Thirion, C.1    Lochmuller, H.2    Ruzsics, Z.3    Boelhauve, M.4    Konig, C.5    Thedieck, C.6
  • 20
    • 22744434147 scopus 로고    scopus 로고
    • Localization of coxsackie virus and adenovirus receptor (CAR) in normal and regenerating human muscle
    • Sinnreich M, Shaw CA, Pari G, Nalbantoglu J, Holland PC, Karpati G. Localization of coxsackie virus and adenovirus receptor (CAR) in normal and regenerating human muscle. Neuromuscul Disord. 2005;15:541-548.
    • (2005) Neuromuscul Disord. , vol.15 , pp. 541-548
    • Sinnreich, M.1    Shaw, C.A.2    Pari, G.3    Nalbantoglu, J.4    Holland, P.C.5    Karpati, G.6
  • 21
    • 0038210219 scopus 로고    scopus 로고
    • Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: Phase ii results of the kuopio angiogenesis trial (KAT)
    • Hedman M, Hartikainen J, Syvanne M, Stjernvall J, Hedman A, Kivela A et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation. 2003;107: 2677-2683.
    • (2003) Circulation , vol.107 , pp. 2677-2683
    • Hedman, M.1    Hartikainen, J.2    Syvanne, M.3    Stjernvall, J.4    Hedman, A.5    Kivela, A.6
  • 22
    • 0036665610 scopus 로고    scopus 로고
    • Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: A randomized, placebo-controlled, double-blinded phase ii study
    • Makinen K, Manninen H, Hedman M, Matsi P, Mussalo H, Alhava E et al. Increased Vascularity Detected by Digital Subtraction Angiography after VEGF Gene Transfer to Human Lower Limb Artery: A Randomized, Placebo-Controlled, Double-Blinded Phase II Study. Mol Ther. 2002;6:127-133.
    • (2002) Mol Ther , vol.6 , pp. 127-133
    • Makinen, K.1    Manninen, H.2    Hedman, M.3    Matsi, P.4    Mussalo, H.5    Alhava, E.6
  • 24
    • 0034022384 scopus 로고    scopus 로고
    • Effective repeat administration with adenovirus vectors to the muscle
    • Chen P, Kovesdi I, Bruder JT. Effective repeat administration with adenovirus vectors to the muscle. Gene Ther. 2000;7:587-595.
    • (2000) Gene Ther , vol.7 , pp. 587-595
    • Chen, P.1    Kovesdi, I.2    Bruder, J.T.3
  • 25
    • 27544513676 scopus 로고    scopus 로고
    • Gutless adenovirus: Last-generation adenovirus for gene therapy
    • S18-S27
    • Alba R, Bosch A, Chillon M. Gutless adenovirus: last-generation adenovirus for gene therapy. Gene Ther. 2005;12 Suppl 1:S18-S27.:S18-S27.
    • (2005) Gene Ther , Issue.12 , pp. S18-S27
    • Alba, R.1    Bosch, A.2    Chillon, M.3
  • 26
    • 0037090776 scopus 로고    scopus 로고
    • Conditional switching of vegf provides new insights into adult neovascularization and pro-angiogenic therapy
    • Dor Y, Djonov V, Abramovitch R, Itin A, Fishman GI, Carmeliet P et al. Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J. 2002;21:1939-1947.
    • (2002) EMBO J. , vol.21 , pp. 1939-1947
    • Dor, Y.1    Djonov, V.2    Abramovitch, R.3    Itin, A.4    Fishman, G.I.5    Carmeliet, P.6
  • 27
    • 0037689525 scopus 로고    scopus 로고
    • Induction of functional neo vascularization by combined VEGF and angiopoietin-1 gene transfer using aav vectors
    • Arsic N, Zentilin L, Zacchigna S, Santoro D, Stanta G, Salvi A et al. Induction of functional neo vascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors. Mol Ther. 2003;7:450-459.
    • (2003) Mol Ther , vol.7 , pp. 450-459
    • Arsic, N.1    Zentilin, L.2    Zacchigna, S.3    Santoro, D.4    Stanta, G.5    Salvi, A.6
  • 28
    • 33847421319 scopus 로고    scopus 로고
    • Vascular endothelial growth factors - biology and current status of clinical applications in cardiovascular medicine
    • Ref Type: In Press
    • Ylä-Herttuala, S., Rissanen, T., Vajanto, I., Hartikainen, J. Vascular endothelial growth factors - biology and current status of clinical applications in cardiovascular medicine. Journal of the American Cardiology of College. 2007. Ref Type: In Press.
    • (2007) Journal of the American Cardiology of College
    • Ylä-Herttuala, S.1    Rissanen, T.2    Vajanto, I.3    Hartikainen, J.4
  • 29
    • 21244441929 scopus 로고    scopus 로고
    • Immune responses to adeno-associated virus vectors
    • Zaiss AK, Muruve DA. Immune responses to adeno-associated virus vectors. Curr Gene Ther. 2005;5:323-331.
    • (2005) Curr Gene Ther. , vol.5 , pp. 323-331
    • Zaiss, A.K.1    Muruve, D.A.2
  • 30
    • 23844487737 scopus 로고    scopus 로고
    • Lentiviral vectors and antiretroviral intrinsic immunity
    • Mangeat B, Trono D. Lentiviral vectors and antiretroviral intrinsic immunity. Hum Gene Ther. 2005;16:913-920.
    • (2005) Hum Gene Ther , vol.16 , pp. 913-920
    • Mangeat, B.1    Trono, D.2
  • 31
  • 32
    • 0035859782 scopus 로고    scopus 로고
    • Adenovirus-mediated gene transfer of VEGF(121) improves lower-extremity endothelial function and flow reserve
    • Rajagopalan S, Shah M, Luciano A, Crystal R, Nabel EG. Adenovirus-mediated gene transfer of vegf(121) improves lower-extremity endothelial function and flow reserve. Circulation. 2001;104:753-755.
    • (2001) Circulation , vol.104 , pp. 753-755
    • Rajagopalan, S.1    Shah, M.2    Luciano, A.3    Crystal, R.4    Nabel, E.G.5
  • 33
    • 0036710990 scopus 로고    scopus 로고
    • Phase i study of direct administration of a replication deficient adenovirus vector containing the vascular endothelial growth factor CDNA (ci-1023) to patients with claudication
    • Rajagopalan S, Trachtenberg J, Mohler E, Olin J, McBride S, Pak R et al. Phase I study of direct administration of a replication deficient adenovirus vector containing the vascular endothelial growth factor cDNA (CI-1023) to patients with claudication. Am J Cardiol. 2002;90:512-516.
    • (2002) Am J Cardiol , vol.90 , pp. 512-516
    • Rajagopalan, S.1    Trachtenberg, J.2    Mohler, E.3    Olin, J.4    Mcbride, S.5    Pak, R.6
  • 34
    • 0036147182 scopus 로고    scopus 로고
    • Analysis of risk factors for local delivery of low- And intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions
    • Crystal RG, Harvey BG, Wisnivesky JP, O'Donoghue KA, Chu KW, Maroni J et al. Analysis of risk factors for local delivery of low- And intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions. Hum Gene Ther. 2002;13:65-100.
    • (2002) Hum Gene Ther , vol.13 , pp. 65-100
    • Crystal, R.G.1    Harvey, B.G.2    Wisnivesky, J.P.3    O'Donoghue, K.A.4    Chu, K.W.5    Maroni, J.6
  • 35
    • 33748155036 scopus 로고    scopus 로고
    • Angiogenic gene therapy in patients with non revascularizable ischemic heart disease: A phase 2 randomized, controlled trial of advegf (121) (advegf121) versus maximum medical treatment
    • Stewart DJ, Hilton JD, Arnold JM, Gregoire J, Rivard A, Archer SL et al. Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease : A phase 2 randomized, controlled trial of AdVEGF (121) (AdVEGF121) versus maximum medical treatment. Gene Ther. 2006.
    • (2006) Gene Ther
    • Stewart, D.J.1    Hilton, J.D.2    Arnold, J.M.3    Gregoire, J.4    Rivard, A.5    Archer, S.L.6
  • 36
    • 0142023866 scopus 로고    scopus 로고
    • Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: A phase ii randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent Claudication
    • Rajagopalan S, Mohler ER, III, Lederman RJ, Mendelsohn FO, Saucedo JF, Goldman CK et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease : A phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation. 2003;108:1933-1938.
    • (2003) Circulation , vol.108 , pp. 1933-1938
    • Rajagopalan, S.1    Mohler, E.R.2    Lederman, R.J.3    Mendelsohn, F.O.4    Saucedo, J.F.5    Goldman, C.K.6
  • 37
    • 0037265253 scopus 로고    scopus 로고
    • Fibroblast growth factor-4 induces vascular permeability, angiogenesis, and arteriogenesis in a rabbit hind limb ischemia model
    • Rissanen TT, Markkanen JE, Arve K, Rutanen J, Kettunen MI, Vajanto I et al. Fibroblast growth factor-4 induces vascular permeability, angiogenesis, and arteriogenesis in a rabbit hind limb ischemia model. FASEB J. 2003;17:100-102.
    • (2003) FASEB J. , vol.17 , pp. 100-102
    • Rissanen, T.T.1    Markkanen, J.E.2    Arve, K.3    Rutanen, J.4    Kettunen, M.I.5    Vajanto, I.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.